| 发明名称 |
Hepatitis C virus inhibitors |
| 摘要 |
Hepatitis C virus inhibitors are disclosed having the general formula:;wherein R1, R2, R3, R′, B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed. |
| 申请公布号 |
US8889871(B2) |
申请公布日期 |
2014.11.18 |
| 申请号 |
US201414183247 |
申请日期 |
2014.02.18 |
| 申请人 |
Bristol-Myers Squibb Company |
发明人 |
Wang Alan Xiangdong;Sun Li-Qiang;Sit Sing-Yuen;Sin Ny;Scola Paul Michael;Chen Yan |
| 分类号 |
C07D217/24;C07D401/12 |
主分类号 |
C07D217/24 |
| 代理机构 |
|
代理人 |
Mingo Pamela A. |
| 主权项 |
1. A compound of formula (3) or a pharmaceutically acceptable salt thereof, wherein:
one of R6, R7, R8, R9, R10, and R11 is methoxy, one is chloro, and the rest are hydrogen;R3 is tert-butyl;B is tert-butoxycarbonyl; andY is hydrogen. |
| 地址 |
Princeton NJ US |
